Advanced search
Publication Cover
Journal of Medical Economics Volume 25, 2022 - Issue 1
Submit an article Journal homepage
2,803
Views
3
CrossRef citations to date
0
Altmetric
Immunology

Budget impact analysis of belumosudil for chronic graft-versus-host disease treatment in the United States

Carlos R. Bachiera Sarah Cannon Transplant and Cellular Therapy Program, Methodist Hospital, San Antonio, TX, USACorrespondence[email protected]
,
Jeffrey R. Skaarb Evidence Strategy, Trinity Life Sciences, Waltham, MA, USA
,
Sumudu Dehipawalab Evidence Strategy, Trinity Life Sciences, Waltham, MA, USA
,
Benjamin Miaob Evidence Strategy, Trinity Life Sciences, Waltham, MA, USAORCID Iconhttps://orcid.org/0000-0002-2550-5027
ORCID Icon,
Jonathan Ieyoubc A Sanofi Company, Kadmon Corporation, LLC, New York, NY, USA
&
Haya Taitelc A Sanofi Company, Kadmon Corporation, LLC, New York, NY, USA
Pages 857-863 | Received 06 Apr 2022, Accepted 06 Jun 2022, Published online: 21 Jun 2022

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.